Study of BC3195 Monotherapy in Patients With Advanced Solid Tumors

Clinical trial NCT05957471 · UNKNOWN

Trial details

NCT number: NCT05957471
Sponsor: Biocity Biopharmaceutics Co., Ltd.
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Advanced or Metastatic Solid Tumors

Start date: 2023-06-26
Primary completion: 2025-06-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.